November 2008 Volume 4, Issue 11

Volume 4, Issue 11 | November 2008

November 2008

In this Issue

Global News

Drug Discovery News Placeholder Image

Focus on emerging markets

GSK snags Egyptian mature products business of Bristol-Myers Squibb for $210 million
Drug Discovery News Placeholder Image

Coming in from the cold

Lipoxen, Cambridge Biostability work to develop improved vaccines that are stable at ambient temperatures
Drug Discovery News Placeholder Image

Pfizer, UCB announce joint venture

New company Cyclofluidic aims to accelerate drug discovery via automating flow chemistry, flow biology
Drug Discovery News Placeholder Image

Theratechnologies, EMD Serono in HIV tesamorelin licensing deal

Theratechnologies Inc. and EMD Serono Inc., an affiliate of Merck KGaA, Darmstadt, Germany, announced the companies entered a collaboration and licensing agreement for the exclusive commercialization rights to tesamorelin in the United States for the treatment of excess abdominal fat in HIV patients with lipodystrophy.
Drug Discovery News Placeholder Image

Pfizer to settle Bextra and Celebrex lawsuits for $894 million

Settlement to resolve personal injury and class action lawsuits, state AG claims

Editor's Focus

Drug Discovery News Placeholder Image

Economic meltdown and where the money is

It’s pretty hard to be the editor of a business publication and not address the recent world-wide economic meltdown. What’s to make of this mess, and what are the potential impacts on the biotech and pharmaceutical industry?

Commentary

Drug Discovery News Placeholder Image

Now what do we do? Challenges abound in life sciences for new graduates and experienced alike

Twenty years ago, life in Big Pharma was genteel and secure. Today, it is neither. There are always good career opportunities for the best, and the only way to be the best is to get to work and not wait for miracles.
Drug Discovery News Placeholder Image

A solid team in the life sciences

Just as our editorial staff delivers the news to our readers, our sales staff delivers integrated marketing opportunities to the advertising community. DDN is very fortunate that in our fourth year, we have a veteran sales team, all of whom have deep and significant experience in life science publishing, to help our advertisers design their own customized integrated marketing programs.

Informatics

Drug Discovery News Placeholder Image

Bringing down Big Pharma's fortress

SIMDAT Project ends with successful virtual outsourcing project at GSK
Drug Discovery News Placeholder Image

Early warning system

CSS Informatics, DrugLogic integrate safety data technologies to allow early detection of adverse trial events
Drug Discovery News Placeholder Image

In-depth in silico discovery

Life Biosystems, Temis solution offers analysis of large-scale bibliographic information
Drug Discovery News Placeholder Image

Gunning for genomics

Integromics, Tibco roll out genomics data analysis solution
Drug Discovery News Placeholder Image

Making massive models

Biogen Idec to process inflammatory disease data using Gene Network Sciences' REFS software

Automation & Instrumentation

Drug Discovery News Placeholder Image

A perfect deal from A to Z

Advalytix to private-label ZyGEM's temperature-controlled extraction technology
Drug Discovery News Placeholder Image

Speeding up ADME

BD Biosciences, BioTrove to provide a solution from sample prep to data analysis
Drug Discovery News Placeholder Image

Radiolabeling for ADME

PerkinElmer launches GMP radiolabeling services
Drug Discovery News Placeholder Image

Invitrogen hepatocytes pair with Qualyst’s B-Clear

In a move that should markedly enhance the market opportunities for Qualyst’s B-Clear hepatocyte research kits and contract services, the company has agreed with Invitrogen to offer hepatocyte screening services and research products through the latter’s wholly-owned subsidiary, CellzDirect.

Feature

Drug Discovery News Placeholder Image

Lighting up in vitro and in vivo work

Imaging technologies, particularly luminescent ones, are increasingly important to discovery/development

Research & Development

Drug Discovery News Placeholder Image

Cooperating for a worthy cause

Eli Lilly, Merck and IDRI tackle global threat of TB
Drug Discovery News Placeholder Image

A partner's partnership

Ligand's acquisition of Pharmacopeia to focus on Big Pharma partnerships
Drug Discovery News Placeholder Image

Easier way to make stem cells

Harvard researchers use chemicals in place of two cancer genes in reprogramming process
Drug Discovery News Placeholder Image

Late-stage letdown

Cell Genesys axes 75 percent of staff after cancelling VITAL-1 Phase III trials
Drug Discovery News Placeholder Image

Better late than never

ARCA biopharma, Nuvelo merger creates late-stage cardiovascular biotech

Genomics & Proteomics

Drug Discovery News Placeholder Image

Getting in touch with our inner germs

NIH kicks off the Human Microbiome Project with first awards
Drug Discovery News Placeholder Image

Slashing genome prices

Complete Genomics promises $5,000 human whole-genome sequencing by next year
Drug Discovery News Placeholder Image

Giving RNAi some lip service

RXi Pharma obtains exclusive worldwide license to technology for the oral RNAi delivery
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Clear sample tubes are shown in a clear tote with red lids in a sample prep robot with a blue and silver industrial lab background.

The crucial role of sample preparation in biotherapy manufacturing

Discover how better sample preparation can unlock improved assay accuracy and analytical results.
A black mosquito is shown on pink human skin against a blurred green backdrop.

Discovering deeper insights into malaria research

Malaria continues to drive urgent research worldwide, with new therapies and tools emerging to combat the parasite’s complex lifecycle and global burden.
Three burgundy round and linear conformations of oligonucleotides are shown against a black background.

Accelerating RNA therapeutic testing with liver microphysiological platforms

Researchers can now study oligonucleotide delivery and efficacy in a system that models a real human liver.
Drug Discovery News March 2025 Issue
Latest IssueVolume 21 • Issue 1 • March 2025

March 2025

March 2025 Issue

Explore this issue